Unknown

Dataset Information

0

Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects.


ABSTRACT: The cardioprotective mechanisms of colchicine in patients with stable ischemic heart disease remain uncertain. We tested varying concentrations of colchicine on platelet activity in vitro and a clinically relevant 1.8-mg oral loading dose administered over 1 h in 10 healthy subjects. Data are shown as median [interquartile range]. Colchicine addition in vitro decreased light transmission platelet aggregation only at supratherapeutic concentrations but decreased monocyte- (MPA) and neutrophil-platelet aggregation (NPA) at therapeutic concentrations. Administration of 1.8 mg colchicine to healthy subjects had no significant effect on light transmission platelet aggregation but decreased the extent of MPA (28 % [22-57] to 22 % [19-31], p?=?0.05) and NPA (19 % [16-59] to 15 % [11-30], p?=?0.01), platelet surface expression of PAC-1 (370 mean fluorescence intensity (MFI) [328-555] to 333 MFI [232-407], p?=?0.02) and P-selectin (351 MFI [269-492] to 279 [226-364], p?=?0.03), and platelet adhesion to collagen (10.2 % [2.5-32.6] to 2.0 % [0.2-9.5], p?=?0.09) 2 h post-administration. Thus, in clinically relevant concentrations, colchicine decreases expression of surface markers of platelet activity and inhibits leukocyte-platelet aggregation but does not inhibit homotypic platelet aggregation.

SUBMITTER: Shah B 

PROVIDER: S-EPMC4753094 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


The cardioprotective mechanisms of colchicine in patients with stable ischemic heart disease remain uncertain. We tested varying concentrations of colchicine on platelet activity in vitro and a clinically relevant 1.8-mg oral loading dose administered over 1 h in 10 healthy subjects. Data are shown as median [interquartile range]. Colchicine addition in vitro decreased light transmission platelet aggregation only at supratherapeutic concentrations but decreased monocyte- (MPA) and neutrophil-pla  ...[more]

Similar Datasets

| S-EPMC8272003 | biostudies-literature
| S-EPMC8619073 | biostudies-literature
| S-EPMC10161605 | biostudies-literature
| S-EPMC6397092 | biostudies-literature
| S-EPMC6566413 | biostudies-literature
| S-EPMC4692430 | biostudies-other
| S-EPMC10219876 | biostudies-literature
| S-EPMC4689902 | biostudies-literature
| S-EPMC9289246 | biostudies-literature
| S-EPMC7452038 | biostudies-literature